These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 39135)
1. Specific membrane-binding of angiotensin II--the role of degradative enzymes. Moore AF; Povinelli MA J Pharm Pharmacol; 1979 Jun; 31(6):375-7. PubMed ID: 39135 [TBL] [Abstract][Full Text] [Related]
2. Possible implication of peptidase activity in different potency of angiotensins II and III for displacing [125I]angiotensin II binding in pig aorta. Fujimoto M; Mihara S; Shigeri Y; Itazaki K Eur J Pharmacol; 1992 May; 215(2-3):259-64. PubMed ID: 1396989 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist. Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838 [TBL] [Abstract][Full Text] [Related]
4. Solubilisation of angiotensin II receptors in rabbit aortae membranes. Devynck MA; Pernollet MG; Meyer P; Fermandjian S; Fromageot P; Bumpus FM Nature; 1974 May; 249(452):67-9. PubMed ID: 4364356 [No Abstract] [Full Text] [Related]
6. Calcium release induced by interaction of angiotensin with its receptors in smooth muscle cell microsomes. Baudouin M; Meyer P; Fermandjian S; Morgat JL Nature; 1972 Feb; 235(5337):336-8. PubMed ID: 4334508 [No Abstract] [Full Text] [Related]
7. Evidence for angiotensin II receptors in the urinary bladder of the rabbit. Anderson GF; Barraco RA; Normile HJ; Rosen TN Can J Physiol Pharmacol; 1984 Apr; 62(4):390-5. PubMed ID: 6329496 [TBL] [Abstract][Full Text] [Related]
8. DuP 532: a second generation of nonpeptide angiotensin II receptor antagonists. Chiu AT; Carini DJ; Duncia JV; Leung KH; McCall DE; Price WA; Wong PC; Smith RD; Wexler RR; Timmermans PB Biochem Biophys Res Commun; 1991 May; 177(1):209-17. PubMed ID: 2043107 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116). Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552 [TBL] [Abstract][Full Text] [Related]
10. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174. Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist. Noda M; Shibouta Y; Inada Y; Ojima M; Wada T; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K Biochem Pharmacol; 1993 Jul; 46(2):311-8. PubMed ID: 8347154 [TBL] [Abstract][Full Text] [Related]
12. Binding and degradation of angiotensin II by mesenteric artery subcellular membranes. Grover AK; Kwan CY; Kostka P; Daniel EE Eur J Pharmacol; 1985 Jun; 112(2):137-43. PubMed ID: 3928392 [TBL] [Abstract][Full Text] [Related]
13. Angiotensinase activity and angiotensin receptor binding in guinea pig aorta. Le Morvan P; Palaic D; Ferguson D Can J Physiol Pharmacol; 1977 Jun; 55(3):652-7. PubMed ID: 195694 [TBL] [Abstract][Full Text] [Related]
14. Receptor binding interactions of the angiotensin II antagonist, 125I-[sarcosine1,leucine8]angiotensin II, with mammalian brain and peripheral tissues. Bennett JP; Snyder SH Eur J Pharmacol; 1980 Oct; 67(1):11-25. PubMed ID: 6252019 [TBL] [Abstract][Full Text] [Related]
16. Sarmesin is a partial agonist of angiotensin-II receptors in rabbit, but not in rat, aortic rings. Criscione L; Thomann H; Whitebread S; de Gasparo M; Kamber B Biochem Biophys Res Commun; 1990 Jun; 169(2):636-42. PubMed ID: 2357223 [TBL] [Abstract][Full Text] [Related]
17. Receptor binding and internalization of a unique biologically active angiotensin II-colloidal gold conjugate: morphological analysis of angiotensin II processing in isolated vascular strips. Anderson KM; Peach MJ J Vasc Res; 1994; 31(1):10-7. PubMed ID: 7903871 [TBL] [Abstract][Full Text] [Related]
18. Non-peptide angiotensin II receptor antagonists. II. Pharmacology of S-8308. Chiu AT; Carini DJ; Johnson AL; McCall DE; Price WA; Thoolen MJ; Wong PC; Taber RI; Timmermans PB Eur J Pharmacol; 1988 Nov; 157(1):13-21. PubMed ID: 3234494 [TBL] [Abstract][Full Text] [Related]
19. Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629. Olins GM; Chen ST; McMahon EG; Palomo MA; Reitz DB Mol Pharmacol; 1995 Jan; 47(1):115-20. PubMed ID: 7838120 [TBL] [Abstract][Full Text] [Related]
20. Characterization of rat intestinal angiotensin II receptors. Schinke M; Doods HN; Ganten D; Wienen W; Entzeroth M Eur J Pharmacol; 1991 Nov; 204(2):165-70. PubMed ID: 1806384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]